We are live on
!
Find out more
Caption Management Portfolio holdings
AUM
$21.5B
Turnover
58.11%
1-Year Est. Return
81.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.74%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
+$2.54B
(+17%)
Cap. Flow
-$40.7M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,194
New
682
Increased
333
Reduced
357
Closed
710
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OWL
|
+$166M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.1M |
| 3 |
NVIDIA
NVDA
|
+$63.6M |
| 4 |
Take-Two Interactive
TTWO
|
+$56.8M |
| 5 |
Global X Cybersecurity ETF
BUG
|
+$23.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$128M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$124M |
| 3 |
Netflix
NFLX
|
+$48.3M |
| 4 |
Microsoft
MSFT
|
+$33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 88.8% |
| 2 | Technology | 2.44% |
| 3 | Healthcare | 2.37% |
| 4 | Consumer Discretionary | 1.9% |
| 5 | Financials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1051
CALL
Blue Owl Capital
OWL
$6.05B
| $913K | 0.01% |
100,000
-110,000
| -52% | -$1.33M |
2025 Q1
4 quarters
|
|
1052
CALL
Immunocore
IMCR
$1.51B
| $905K | 0.01% |
+30,000
| New | +$971K |
2026 Q1
0 quarters
|
|
1053
CALL
eToro Group
ETOR
$1.94B
| $901K | 0.01% |
30,000
| – | – |
2025 Q4
1 quarter
|
|
1054
CALL
Ardelyx
ARDX
$798M
| $899K | 0.01% |
150,000
+108,800
| +264% | +$720K |
2025 Q4
1 quarter
|
|
1055
CALL
Uniti Group
UNIT
$1.36B
| $891K | 0.01% |
+95,000
| New | +$745K |
2026 Q1
0 quarters
|
|
1056
Evolus
EOLS
$469M
| $889K | 0.01% |
+216,316
| New | +$1.05M |
2026 Q1
0 quarters
|
|
1057
PUT
Bicara Therapeutics
BCAX
$1.11B
| $887K | 0.01% |
44,600
| – | – |
2025 Q4
1 quarter
|
|
1058
CALL
Zevra Therapeutics
ZVRA
$590M
| $886K | 0.01% |
95,100
-1,105,300
| -92% | -$9.96M |
2025 Q2
3 quarters
|
|
1059
Amcor
AMCR
$20.3B
| $885K | 0.01% |
22,271
-17,729
| -44% | -$784K |
2024 Q4
5 quarters
|
|
1060
PUT
Aurinia Pharmaceuticals
AUPH
$2.2B
| $885K | 0.01% |
59,700
+19,700
| +49% | +$288K |
2024 Q2
7 quarters
|
|
1061
PUT
Shake Shack
SHAK
$2.83B
| $885K | 0.01% |
10,000
| – | – |
2025 Q1
4 quarters
|
|
1062
Viridian Therapeutics
VRDN
$2.16B
| $883K | 0.01% |
+45,127
| New | +$1.34M |
2026 Q1
0 quarters
|
|
1063
Bitdeer Technologies
BTDR
$2.1B
| $880K | 0.01% |
101,736
-68,264
| -40% | -$717K |
2025 Q3
2 quarters
|
|
1064
Eos Energy Enterprises
EOSE
$663M
| $875K | 0.01% |
176,400
-738,327
| -81% | -$7.93M |
2025 Q3
2 quarters
|
|
1065
The GEO Group
GEO
$3.77B
| $869K | 0.01% |
51,699
-9,917
| -16% | -$158K |
2024 Q2
7 quarters
|
|
1066
Venture Global Inc
VG
$31.8B
| $867K | 0.01% |
55,000
-17,800
| -24% | -$191K |
2025 Q1
4 quarters
|
|
1067
Goodyear
GT
$1.24B
| $862K | 0.01% |
130,000
-13,734
| -10% | -$116K |
2025 Q4
1 quarter
|
|
1068
CALL
Magna International
MGA
$17.7B
| $859K | 0.01% |
+15,400
| New | +$879K |
2026 Q1
0 quarters
|
|
1069
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$734M
| $858K | 0.01% |
241,600
-835,000
| -78% | -$3.42M |
2025 Q3
2 quarters
|
|
|
TWO
1070
PUT
DELISTED
Two Harbors Investment
TWO
| $857K | 0.01% |
+75,000
| New | +$840K |
2026 Q1
0 quarters
|
|
1071
CALL
Amprius Technologies
AMPX
$1.13B
| $843K | ﹤0.01% |
+50,000
| New | +$652K |
2026 Q1
0 quarters
|
|
1072
FIVE9
FIVN
$2.41B
| $840K | ﹤0.01% |
55,395
+26,321
| +91% | +$457K |
2025 Q3
2 quarters
|
|
1073
Badger Meter
BMI
$3.67B
| $838K | ﹤0.01% |
+5,500
| New | +$863K |
2026 Q1
0 quarters
|
|
1074
CALL
Burford Capital
BUR
$659M
| $833K | ﹤0.01% |
184,300
| – | – |
2025 Q4
1 quarter
|
|
1075
PUT
Cedar Fair
FUN
$830M
| $832K | ﹤0.01% |
46,900
| – | – |
2025 Q4
1 quarter
|
|
Similar funds
Caption Management's Q1 2026 Portfolio in Review
As of Q1 2026, Caption Management held 2,194 positions worth $17.1B, up 17% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Caption Management's Q1 2026 filing shows 682 new, 333 increased, 357 reduced and 710 closed positions. Its largest new stake was Meta Platforms (Facebook): 112,500 shares worth $64.4M. The largest sale was Apple, an estimated $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 85% a quarter earlier, followed by Technology and Healthcare.
- Caption Management's largest Q1 2026 buy was Meta Platforms (Facebook): 112,500 shares worth $64.4M.
- Caption Management added most to Blue Owl Capital in Q1 2026, an estimated $166M increase.
- Caption Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $124M.
- Caption Management fully exited Apple in Q1 2026, selling an estimated $128M.
- Caption Management's ten largest holdings make up 22% of its $17.1B portfolio in Q1 2026.
- Caption Management opened 682 new positions and closed 710 in Q1 2026.
- Caption Management's portfolio value rose 17% quarter-over-quarter to $17.1B.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.